Vice Chair, Department of Dermatology, Mayo Clinic Arizona
Dermatology
Dr. Aleksandar Sekulic, MD
|
|
Give Review
Aleksandar Sekulic, MD practices Dermatology. He has 2 awards "Top Doctors:Arizona State" and "Fellow (FAAD)". Aleksandar Sekulic is also published. He has 21 publications published. The lastest publication: "Polyomavirus middle T antigen as a probe for T cell antigen receptor-coupled signaling pathways.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Hedgehog Pathway Inhibition.
- Chronic Interstitial Granulomatous Dermatitis in Coccidioidomycosis.
- Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion.
- Cutaneous adverse effects of targeted therapies: Part I: Inhibitors of the Cellular membrane.
- Cutaneous adverse effects of targeted therapies: Part II: Inhibitors of intraCellular molecular signaling pathways.
- Vemurafenib-associated gingival hyperplasia in patient with metastatic Melanoma.
- Treatment of epidermolysis bullosa pruriginosa using systemic and topical agents.
- Small Cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4.
- Advanced Basal cell carcinoma of the skin: targeting the hedgehog pathway.
- Efficacy and safety of vismodegib in advanced Basal-cell carcinoma.
- A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed Cells.
- Polyomavirus middle T antigen as a probe for T Cell antigen receptor-coupled signaling pathways.
- Activating BRAF mutations in eruptive melanocytic naevi.
- Metastatic malignant Melanoma.
- Malignant Melanoma in the elderly: different regional disease and poorer prognosis.
- The impact of biopsy technique on upstaging, residual disease, and outcome in cutaneous Melanoma.
- Risk factors associated with local and in-transit recurrence of cutaneous Melanoma.
- Loss of inositol polyphosphate 5-phosphatase is an early event in development of cutaneous squamous Cell carcinoma.
- Does sunscreen prevent epidermal growth factor receptor (EGFR) inhibitor-induced Rash? Results of a placebo-controlled trial from the North Central Cancer Treatment Gr...
- Malignant Melanoma in the 21st century: the emerging molecular landscape.
Procedures Preformed
- Destruction of Benign Skin Lesion
- Destruction of Malignant Skin Lesion
- Excision of Malignant Skin Lesion
Conditions Treated
- Actinic Keratosis
- Basal Cell Carcinoma
- Benign Skin Lesion
- Carcinoma in Situ of Skin
- View All
Doctors Specialties
- Dermatology
Accepted Insurances
Awards
- Top Doctors:Arizona State
- Fellow (FAAD)
Education
-
Mayo School of Graduate Medical Education -
University of Zagreb Faculty of Medicine
Hospital
-
Mayo Clinic - Phoenix/Scottsdale, Arizona
Drug Facts
| NPI NUMBER | 1235118340 | |
| NPPES Provider LastName | SEKULIC | |
| NPPES Provider FirstName | ALEKSANDAR | |
| NPPES Provider ZIPCode | 852595404 | |
| NPPES Provider State | AZ | |
| Specialty Description | Dermatology | |
| Total Claim Count | 235.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1235118340 |
| Last Name Of The Provider | SEKULIC |
| First Name Of The Provider | ALEKSANDAR |
| View All |
Similar Doctors
|
|
Dr. Anna Levin, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Anthony A. Nuara, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Miriam P. Cummings, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Bill H. Halmi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph S. Machuzak, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katherine K. Quan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shanon I. Heck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Henry H. Roenigk, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Jessica L. Rosenblum, PA-C
This Doctor is OpenDoctor Recommended.
|
|
David Feist, PA-C |